X-Message-Number: 10659 Date: Fri, 30 Oct 1998 15:58:15 -0500 From: Jan Coetzee <> Subject: New brain cells for old ones. DOGMA OVERTURNED Upending a long-held theory, a study finds that humans can grow new brain neurons throughout life--even into old age Rats can do it. So can opossums, songbirds, marmosets--why, even tree shrews. But every biology student is taught that humans cannot produce new neurons anywhere in their brains once they have matured. That is a limitation--damage from abuse, disease and injury never heals--but it is also an evolutionary advantage, because it means that memories, imprinted in webs of neurons, can persist undisturbed for a lifetime. Or so the theory has gone for more than a decade. Now it appears that that fundamental dogma of medicine is wrong; at the very least, it is far too sweeping. Two neuroscientists, one American and one Swedish, have collected the first persuasive evidence that mature, even elderly, people do create additional neurons by the hundreds in at least one important part of the brain, a section of the hippocampus called the dentate gyrus. At press time, the paper was still under review for publication by Nature Medicine. The scientists do not know what the new cells do nor whether the same process, called neurogenesis, occurs elsewhere in the brain. But others in the field say that even though the discovery probably will not yield medical applications for many years, it is a major advance nonetheless. "Once you accept that the brain has some plasticity after all, you have to rethink approaches to lots of problems," says Gerd Kempermann of the University of Regensburg in Germany. For more than two years, Fred H. Gage of the Salk Institute in San Diego and Peter S. Eriksson of the G teborg University Institute of Clinical Neuroscience conducted an experiment that was thought to be nearly impossible, for two reasons. First, they needed fresh brain tissue but not from just any spot. The best place to look for newly formed neurons is the hippocampus, which is where they are produced most often in lower mammals. But the hippocampus is nestled deep in the temporal lobes of the brain. "It is very fragile," Eriksson says, and damage to it can destroy a person's ability to learn, because it appears to control which experiences are filed away into long-term storage and which pass into oblivion. Biopsies are thus out of the question. The second problem, Gage explains as he opens a door in his San Diego laboratory to reveal a darkened room full of postdoctoral researchers looking at brain cells through high-tech laser microscopes, is that 60-day-old neurons look just the same as 60-year-old ones. The only well-accepted way to mark nascent cells, neurons or otherwise, is to inject the subject with either tritiated thymidine or bromodeoxyuridine (BrdU), chemicals that can serve as a building block of DNA but that can be detected by film or fluorescence. Cells won't take up these chemicals until they begin to divide and manufacture DNA. When that happens, some of the chemical will be incorporated into the DNA of the offspring, and the young cells will shine for the camera. Unfortunately, both tagging chemicals are toxic to humans. So when Eriksson, on sabbatical at Salk in 1995, began talking to Gage about searching for neurogenesis in humans, there seemed no ethical way to do it. But after Eriksson returned to Sweden, he found a way. "One day I met this oncologist in the operating room; we were both on call," Eriksson remembers. "I asked him whether he knew anyone giving BrdU to patients, and he said yes; in fact, he knew of a study in which seven people with cancer of the tongue or larynx were getting it." Because newborn cells take up BrdU, researchers can use it to help monitor how fast a tumor is growing. Eriksson tracked down the doctor in charge of the study, and they made a deal: whenever one of the patients died, the doctor would ask the family's permission to remove the hippocampus. If they agreed, then Eriksson would be summoned. Five times from 1996 until this past February, Eriksson got a call, then jumped in the car and sped over to the hospital to watch as a pathologist pulled out a fingertip-size lump of brain--still warm in one instance--from cadavers aged 57 to 72. He then immediately stained the samples with NeuN, a marker that (as far as is known) attaches only to neurons. "You need to get the samples within 24 hours, before the cells lose too much of their integrity," Eriksson explains. But the boyish, normally jovial face of the 39-year-old scientist falls as he allows that the work was a touch gruesome. "When your success is based on someone's death, it makes you sad," he says. "It was heartening, though, to tell the families about what good might come from the results of the experiment." Indeed, the results were surprising. Stepping layer by layer through the stained sections of the dentate gyrus with their laser microscopes, the scientists saw cell after cell lit both green and red. The green meant that the cells had picked up BrdU and thus must have been born while the chemical was in the bloodstream, during the patients' cancer treatments. The red came from NeuN, indicating that the new cells were indeed neurons. "It was an amazing feeling to see them, in every sample, right where we expected they would be," Gage says. "Neurogenesis occurs, and it occurs throughout life. More than that, these new neurons survive for years." One of the patients had received his last BrdU injection 781 days before his death. "Most important," Gage adds, "it is not an isolated, rare event." In all five patients, each cubic millimeter of dentate gyrus held 100 to 300 newly fledged neurons. That may not sound like a lot, especially considering that the dentate gyrus is no bigger than a BB. But a few neurons can go a long way, Kempermann points out. "Fewer than 50 cells are thought to control breathing," he says; damage to a couple thousand neurons by Parkinson's disease can cause terrible debility. By the same token, adding a few new neurons to a damaged part of the brain might help the organ repair itself. "That is the real significance of this work," says Pasko Rakic, head of the neurobiology department at Yale University and a chief proponent of the no-new-neurons theory. "To be useful, new neurons must develop connections with their neighbors. [Gage and Eriksson] haven't shown that that happens. And new cells have not been shown in the cerebellum, the cerebral cortex or the thalamus," regions most often damaged by injury or disease. "But this work does suggest the possibility of finding a factor that can encourage cell proliferation elsewhere in the brain." "It allows us to think about growing neurons for transplantation," Eriksson elaborates. "In experiments at the University of Lund, transplanted fetal cells greatly reduced the symptoms of Parkinson's disease, an effect that lasted for years. But there are ethical concerns with using cells from aborted fetuses." Now there can be reasonable hope of eventually using adult tissue instead. Such clinical benefits, Eriksson predicts, "are 10 years away, at best." Gage concurs: "Nothing here can be immediately translated to help a person in a wheelchair." That will have to wait until scientists learn much more about where the progenitor cells that give birth to new neurons exist in the brain, what chemical signals spur them to divide, and what determines whether newly created cells become neurons or some other kind of brain matter. Both scientists have animal experiments under way to tackle those tough questions. But it may be years before their peers elsewhere can arrange to get the human tissue needed to confirm their discovery and to build sound medicine on it. So, most likely, "the general spirit of the dogma will live on," Eriksson concedes. "This represents one exception to it; that's all." But where there once seemed only an impenetrable wall, the outline of a door has appeared. --W. Wayt Gibbs in San Diego and G teborg, Sweden Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=10659